{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T07:09:29Z","timestamp":1785654569799,"version":"3.56.0"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100015382","name":"Universiti Sultan Zainal Abidin","doi-asserted-by":"publisher","award":["UniSZA\/2021\/DPU1.0\/15"],"award-info":[{"award-number":["UniSZA\/2021\/DPU1.0\/15"]}],"id":[{"id":"10.13039\/501100015382","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015382","name":"Universiti Sultan Zainal Abidin","doi-asserted-by":"publisher","award":["R0319"],"award-info":[{"award-number":["R0319"]}],"id":[{"id":"10.13039\/501100015382","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vascular Pharmacology"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.vph.2024.107414","type":"journal-article","created":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T13:10:35Z","timestamp":1722345035000},"page":"107414","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Exploring bradykinin: A common mediator in the pathophysiology of sepsis and atherosclerotic cardiovascular disease"],"prefix":"10.1016","volume":"156","author":[{"given":"Mohd Zahari","family":"Siti-Zubaidah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harman-Shah","family":"Harafinova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullahi Nuradeen","family":"Liba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Luqman","family":"Nordin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamarul Ariffin","family":"Hambali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hawa Nordin","family":"Siti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vph.2024.107414_bb0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13054-021-03816-x","article-title":"Why the renin\u2013angiotensin\u2013aldosterone system (RAAS) in critically ill patients can no longer be ignored","volume":"25","author":"Zarbock","year":"2021","journal-title":"Crit. Care"},{"issue":"9","key":"10.1016\/j.vph.2024.107414_bb0010","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/s41569-021-00552-1","article-title":"Interplay between inflammation and thrombosis in cardiovascular pathology","volume":"18","author":"Stark","year":"2021","journal-title":"Nat. Rev. Cardiol."},{"issue":"3","key":"10.1016\/j.vph.2024.107414_bb0015","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1055\/a-2165-1142","article-title":"Phenotypes of disseminated intravascular coagulation","volume":"124","author":"Wada","year":"2024","journal-title":"Thromb. Haemost."},{"issue":"2","key":"10.1016\/j.vph.2024.107414_bb0020","doi-asserted-by":"crossref","first-page":"369","DOI":"10.4049\/jimmunol.1801167","article-title":"Upregulation of proinflammatory bradykinin peptides in systemic lupus erythematosus and rheumatoid arthritis","volume":"205","author":"Vanarsa","year":"2020","journal-title":"J. Immunol."},{"key":"10.1016\/j.vph.2024.107414_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112429","article-title":"The versatile role of the contact system in cardiovascular disease, inflammation, sepsis and cancer","volume":"145","author":"Oehmcke-Hecht","year":"2022","journal-title":"Biomed. Pharmacother."},{"issue":"11","key":"10.1016\/j.vph.2024.107414_bb0030","doi-asserted-by":"crossref","first-page":"e1063","DOI":"10.1097\/CCM.0000000000005337","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021","volume":"49","author":"Evans","year":"2021","journal-title":"Crit. Care Med."},{"issue":"5","key":"10.1016\/j.vph.2024.107414_bb0035","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.arcmed.2015.06.006","article-title":"Global overview of the epidemiology of atherosclerotic cardiovascular disease","volume":"46","author":"Barquera","year":"2015","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.vph.2024.107414_bb0040","article-title":"PAMPs and DAMPs as the bridge between periodontitis and atherosclerosis: the potential therapeutic targets","volume":"10","author":"Zhu","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.vph.2024.107414_bb0045","doi-asserted-by":"crossref","first-page":"108","DOI":"10.3389\/fcell.2019.00108","article-title":"Sepsis: inflammation is a necessary evil","volume":"7","author":"Nedeva","year":"2019","journal-title":"Front. Cell Dev. Biol."},{"issue":"9","key":"10.1016\/j.vph.2024.107414_bb0050","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24097910","article-title":"Atherosclerosis and inflammation: insights from the theory of general pathological processes","volume":"24","author":"Gusev","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.vph.2024.107414_bb0055","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/s41392-022-00955-7","article-title":"Inflammation and atherosclerosis: signaling pathways and therapeutic intervention","volume":"7","author":"Kong","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"issue":"3","key":"10.1016\/j.vph.2024.107414_bb0060","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1182\/blood-2012-04-424143","article-title":"Tissue factor promotes activation of coagulation and inflammation in a mouse model of sickle cell disease","volume":"120","author":"Chantrathammachart","year":"2012","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.vph.2024.107414_bb0065","doi-asserted-by":"crossref","first-page":"27","DOI":"10.5551\/jat.RV17014","article-title":"Mechanism of development of atherosclerosis and cardiovascular disease in diabetes mellitus","volume":"25","author":"Katakami","year":"2018","journal-title":"J. Atheroscler. Thromb."},{"issue":"22","key":"10.1016\/j.vph.2024.107414_bb0070","doi-asserted-by":"crossref","first-page":"3887","DOI":"10.3889\/oamjms.2019.526","article-title":"Atherosclerosis prediction with high sensitivity C-reactive protein (hs-CRP) and related risk factor in patient with dyslipidemia","volume":"7","author":"Swastini","year":"2019","journal-title":"Open Access Maced. J. Med. Sci."},{"key":"10.1016\/j.vph.2024.107414_bb0075","doi-asserted-by":"crossref","DOI":"10.1155\/2009\/106145","article-title":"The levels of tumor necrosis factor-alpha and interleukin-6 in patients with isolated coronary artery ectasia","volume":"2009","author":"Aydin","year":"2009","journal-title":"Mediat. Inflamm."},{"issue":"5","key":"10.1016\/j.vph.2024.107414_bb0080","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1096\/fj.201601326R","article-title":"It\u2019s time to redefine inflammation","volume":"31","author":"Antonelli","year":"2017","journal-title":"FASEB J."},{"issue":"16","key":"10.1016\/j.vph.2024.107414_bb0085","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23169133","article-title":"Renin as a marker of tissue perfusion, septic shock and mortality in septic patients: a prospective observational study","volume":"23","author":"Le\u015bnik","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.vph.2024.107414_bb0090","doi-asserted-by":"crossref","first-page":"e22","DOI":"10.1097\/SHK.0000000000001285","article-title":"Plasma renin concentration is associated with hemodynamic deficiency and adverse renal outcome in septic shock","volume":"52","author":"Nguyen","year":"2019","journal-title":"Shock"},{"issue":"5","key":"10.1016\/j.vph.2024.107414_bb0095","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.3892\/etm.2014.1566","article-title":"Severe sepsis: low expression of the renin-angiotensin system is associated with poor prognosis","volume":"7","author":"Zhang","year":"2014","journal-title":"Exp. Ther. Med."},{"issue":"1","key":"10.1016\/j.vph.2024.107414_bb0100","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/s13054-023-04518-2","article-title":"Increasing angiotensin-converting enzyme concentrations and absent angiotensin-converting enzyme activity are associated with adverse kidney outcomes in pediatric septic shock","volume":"27","author":"Pode-Shakked","year":"2023","journal-title":"Crit. Care"},{"issue":"7","key":"10.1016\/j.vph.2024.107414_bb0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0270920","article-title":"ACE2-like enzyme B38-CAP suppresses abdominal sepsis and severe acute lung injury","volume":"17","author":"Minato","year":"2022","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.vph.2024.107414_bb0110","doi-asserted-by":"crossref","first-page":"3000","DOI":"10.4049\/jimmunol.1900579","article-title":"A dynamic variation of pulmonary ACE2 is required to modulate neutrophilic inflammation in response to Pseudomonas aeruginosa lung infection in mice","volume":"203","author":"Sodhi","year":"2019","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.vph.2024.107414_bb0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0180712","article-title":"Renin inhibition improves metabolic syndrome, and reduces angiotensin II levels and oxidative stress in visceral fat tissues in fructose-fed rats","volume":"12","author":"Chou","year":"2017","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.vph.2024.107414_bb0120","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1001\/jamainternmed.2014.348","article-title":"Effect of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on all-cause mortality, cardiovascular deaths, and cardiovascular events in patients with diabetes mellitus: a meta-analysis","volume":"174","author":"Cheng","year":"2014","journal-title":"JAMA Intern. Med."},{"issue":"10256","key":"10.1016\/j.vph.2024.107414_bb0125","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/S0140-6736(20)31964-4","article-title":"Plasma ACE2 and risk of death or cardiometabolic diseases: a case-cohort analysis","volume":"396","author":"Narula","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.vph.2024.107414_bb0130","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.798958","article-title":"Endothelial dysfunction in hypertension: current concepts and clinical implications","volume":"8","author":"Gallo","year":"2022","journal-title":"Front. Med."},{"key":"10.1016\/j.vph.2024.107414_bb0135","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.ijcard.2015.03.059","article-title":"Endogenous activated angiotensin-(1-7) plays a protective effect against atherosclerotic plaques unstability in high fat diet fed ApoE knockout mice","volume":"184","author":"Yang","year":"2015","journal-title":"Int. J. Cardiol."},{"issue":"2","key":"10.1016\/j.vph.2024.107414_bb0140","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1161\/HYPERTENSIONAHA.111.177485","article-title":"Angiotensin-(1-9) attenuates cardiac fibrosis in the stroke-prone spontaneously hypertensive rat via the angiotensin type 2 receptor","volume":"59","author":"Flores-Munoz","year":"2012","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/j.vph.2024.107414_bb0145","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s00380-019-01478-y","article-title":"Relationship between circulating levels of angiotensin-converting enzyme 2-angiotensin-(1-7)-MAS axis and coronary heart disease","volume":"35","author":"Zhou","year":"2020","journal-title":"Heart Vessel."},{"issue":"6","key":"10.1016\/j.vph.2024.107414_bb0150","doi-asserted-by":"crossref","first-page":"904","DOI":"10.3390\/polym13060904","article-title":"Antimicrobial actions and applications of chitosan","volume":"13","author":"Ke","year":"2021","journal-title":"Polymers"},{"key":"10.1016\/j.vph.2024.107414_bb0155","doi-asserted-by":"crossref","first-page":"66","DOI":"10.3389\/fmed.2018.00066","article-title":"Cell receptor and cofactor interactions of the contact activation system and factor XI","volume":"5","author":"Pathak","year":"2018","journal-title":"Front. Med."},{"key":"10.1016\/j.vph.2024.107414_bb0160","article-title":"Tissue factor-enriched neutrophil extracellular traps promote immunothrombosis and disease progression in sepsis-induced lung injury","volume":"11","author":"Zhang","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"4","key":"10.1016\/j.vph.2024.107414_bb0165","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1161\/ATVBAHA.117.309846","article-title":"Tissue factor: an essential mediator of hemostasis and trigger of thrombosis","volume":"38","author":"Grover","year":"2018","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"12","key":"10.1016\/j.vph.2024.107414_bb0170","doi-asserted-by":"crossref","DOI":"10.3390\/cells11121919","article-title":"The fatal circle of NETs and NET-associated DAMPs contributing to organ dysfunction","volume":"11","author":"Block","year":"2022","journal-title":"Cells"},{"issue":"36","key":"10.1016\/j.vph.2024.107414_bb0175","doi-asserted-by":"crossref","first-page":"15880","DOI":"10.1073\/pnas.1005743107","article-title":"Extracellular DNA traps promote thrombosis","volume":"107","author":"Fuchs","year":"2010","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.vph.2024.107414_bb0180","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.3389\/fimmu.2019.02011","article-title":"Roles of factor XII in innate immunity","volume":"10","author":"Renn\u00e9","year":"2019","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.vph.2024.107414_bb0185","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1010227","article-title":"Fibrin(ogen) engagement of S. aureus promotes the host antimicrobial response and suppression of microbe dissemination following peritoneal infection","volume":"18","author":"Negr\u00f3n","year":"2022","journal-title":"PLoS Pathog."},{"issue":"1","key":"10.1016\/j.vph.2024.107414_bb0190","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jaci.2009.02.006","article-title":"Factor XII\u2013independent cleavage of high-molecular-weight kininogen by prekallikrein and inhibition by C1 inhibitor","volume":"124","author":"Joseph","year":"2009","journal-title":"J. Allergy Clin. Immunol."},{"issue":"1","key":"10.1016\/j.vph.2024.107414_bb0195","doi-asserted-by":"crossref","DOI":"10.1515\/med-2023-0741","article-title":"Low Ang-(1\u20137) and high des-Arg9 bradykinin serum levels are correlated with cardiovascular risk factors in patients with COVID-19","volume":"18","author":"Rostamzadeh","year":"2023","journal-title":"Open Med."},{"issue":"1","key":"10.1016\/j.vph.2024.107414_bb0200","first-page":"H275","article-title":"Bradykinin and des-Arg9-bradykinin metabolic pathways and kinetics of activation of human plasma","volume":"281","author":"Cyr","year":"2001","journal-title":"Am. J. Phys. Heart Circ. Phys."},{"issue":"4","key":"10.1016\/j.vph.2024.107414_bb0205","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1016\/j.ajog.2005.03.022","article-title":"The syndrome of amniotic fluid embolism: a potential contribution of bradykinin","volume":"193","author":"Robillard","year":"2005","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"50","key":"10.1016\/j.vph.2024.107414_bb0210","doi-asserted-by":"crossref","first-page":"31822","DOI":"10.1016\/S0021-9258(18)31769-1","article-title":"The carboxyl terminus of bradykinin and amino terminus of the light chain of kininogens comprise an endothelial cell binding domain","volume":"269","author":"Hasan","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.vph.2024.107414_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102908","article-title":"Kininogen supports inflammation and bacterial spreading during streptococccus pyogenes sepsis","volume":"58","author":"K\u00f6hler","year":"2020","journal-title":"EBioMedicine"},{"issue":"17","key":"10.1016\/j.vph.2024.107414_bb0220","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1182\/blood-2017-04-569111","article-title":"Coagulation factor XII in thrombosis and inflammation","volume":"131","author":"Maas","year":"2018","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.vph.2024.107414_bb0225","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1096\/fj.03-0835fje","article-title":"Interactions between bradykinin (BK) and cell adhesion molecule (CAM) expression in peptidoglycan-polysaccharide (PG-PS)-induced arthritis","volume":"18","author":"Sainz","year":"2004","journal-title":"FASEB J."},{"key":"10.1016\/j.vph.2024.107414_bb0230","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2019.00624","article-title":"The effects of bradykinin B1 receptor antagonism on the myocardial and vascular consequences of hypertension in SHR rats","volume":"10","author":"Deres","year":"2019","journal-title":"Front. Physiol."},{"issue":"6","key":"10.1016\/j.vph.2024.107414_bb0235","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1161\/01.RES.75.6.1064","article-title":"des-Arg9-bradykinin produces tone-dependent kinin B1 receptor-mediated responses in the pulmonary vascular bed","volume":"75","author":"DeWitt","year":"1994","journal-title":"Circ. Res."},{"issue":"10","key":"10.1016\/j.vph.2024.107414_bb0240","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1084\/jem.20042041","article-title":"Induction of vascular leakage through release of bradykinin and a novel kinin by cysteine proteinases from Staphylococcus aureus","volume":"201","author":"Imamura","year":"2005","journal-title":"J. Exp. Med."},{"issue":"11","key":"10.1016\/j.vph.2024.107414_bb0245","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0080348","article-title":"Type 2 diabetes elicits lower nitric oxide, bradykinin concentration and kallikrein activity together with higher desArg9-BK and reduced post-exercise hypotension compared to non-diabetic condition","volume":"8","author":"Simoes","year":"2013","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.vph.2024.107414_bb0250","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1097\/SHK.0b013e3182336a34","article-title":"The role of bradykinin and the effect of the bradykinin receptor antagonist icatibant in porcine sepsis","volume":"36","author":"Barratt-Due","year":"2011","journal-title":"Shock"},{"issue":"0910","key":"10.1016\/j.vph.2024.107414_bb0255","doi-asserted-by":"crossref","first-page":"142","DOI":"10.4414\/smw.2008.11788","article-title":"Contact system activation in human sepsis-47kD HK, a marker of sepsis severity?","volume":"138","author":"Asmis","year":"2008","journal-title":"Swiss Med. Wkly."},{"key":"10.1016\/j.vph.2024.107414_bb0260","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40635-019-0228-3","article-title":"Bradykinin receptor deficiency or antagonism do not impact the host response during gram-negative pneumonia-derived sepsis","volume":"7","author":"Ding","year":"2019","journal-title":"Intensive Care Med. Exp."},{"issue":"4","key":"10.1016\/j.vph.2024.107414_bb0265","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1093\/infdis\/jiv426","article-title":"Kinin B1 receptor inhibition with BI113823 reduces inflammatory response, mitigates organ injury, and improves survival among rats with severe sepsis","volume":"213","author":"Murugesan","year":"2016","journal-title":"J. Infect. Dis."},{"issue":"6","key":"10.1016\/j.vph.2024.107414_bb0270","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1001\/jama.1997.03540300050033","article-title":"Treatment of severe systemic inflammatory response syndrome and sepsis with a novel bradykinin antagonist, deltibant (CP-0127). Results of a randomized, double-blind, placebo-controlled trial. CP-0127 SIRS and Sepsis study group","volume":"277","author":"Fein","year":"1997","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.vph.2024.107414_bb0275","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/clpt.2012.249","article-title":"Contribution of endogenous bradykinin to fibrinolysis, inflammation, and blood product transfusion following cardiac surgery: a randomized clinical trial","volume":"93","author":"Balaguer","year":"2013","journal-title":"Clin. Pharmacol. Ther. (St. Louis, MO, U. S.)"},{"issue":"1","key":"10.1016\/j.vph.2024.107414_bb0280","doi-asserted-by":"crossref","DOI":"10.21037\/atm-22-6016","article-title":"Recombinant human angiotensin-converting enzyme 2 plays a protective role in mice with sepsis-induced cardiac dysfunction through multiple signaling pathways dependent on converting angiotensin II to angiotensin 1\u20137","volume":"11","author":"Wu","year":"2023","journal-title":"Ann. Transl. Med."},{"issue":"2","key":"10.1016\/j.vph.2024.107414_bb0285","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1177\/1470320313491794","article-title":"Vascular angiotensin II type 2 receptor attenuates atherosclerosis via a kinin\/NO-dependent mechanism","volume":"16","author":"Takata","year":"2015","journal-title":"J. Renin-Angiotensin-Aldosterone Syst."},{"issue":"18","key":"10.1016\/j.vph.2024.107414_bb0290","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1056\/NEJM199810293391804","article-title":"Effect of bradykinin-receptor blockade on the response to angiotensin-converting\u2013enzyme inhibitor in normotensive and hypertensive subjects","volume":"339","author":"Gainer","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.vph.2024.107414_bb0295","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3389\/fmed.2019.00032","article-title":"Increased reactive oxygen species generation contributes to the atherogenic activity of the B2 bradykinin receptor","volume":"6","author":"Perhal","year":"2019","journal-title":"Front. Med. (Lausanne)"},{"issue":"4","key":"10.1016\/j.vph.2024.107414_bb0300","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1159\/000438526","article-title":"Exogenous bradykinin inhibits tissue factor induction and deep vein thrombosis via activating the eNOS\/phosphoinositide 3-kinase\/Akt signaling pathway","volume":"37","author":"Dong","year":"2015","journal-title":"Cell. Physiol. Biochem."},{"issue":"3","key":"10.1016\/j.vph.2024.107414_bb0305","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1182\/blood-2007-06-092338","article-title":"Deletion of murine kininogen gene 1 (mKng1) causes loss of plasma kininogen and delays thrombosis","volume":"111","author":"Merkulov","year":"2008","journal-title":"Blood"},{"issue":"19","key":"10.1016\/j.vph.2024.107414_bb0310","doi-asserted-by":"crossref","first-page":"4082","DOI":"10.1182\/blood-2012-06-440057","article-title":"Kininogen deficiency protects from ischemic neurodegeneration in mice by reducing thrombosis, blood-brain barrier damage, and inflammation","volume":"120","author":"Langhauser","year":"2012","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.vph.2024.107414_bb0315","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jtha.2022.11.011","article-title":"Severe high-molecular-weight kininogen deficiency: clinical characteristics, deficiency-causing KNG1 variants, and estimated prevalence","volume":"21","author":"Adenaeuer","year":"2023","journal-title":"J. Thromb. Haemost."}],"container-title":["Vascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S153718912400140X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S153718912400140X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T20:26:32Z","timestamp":1778617592000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S153718912400140X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":63,"alternative-id":["S153718912400140X"],"URL":"https:\/\/doi.org\/10.1016\/j.vph.2024.107414","relation":{},"ISSN":["1537-1891"],"issn-type":[{"value":"1537-1891","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring bradykinin: A common mediator in the pathophysiology of sepsis and atherosclerotic cardiovascular disease","name":"articletitle","label":"Article Title"},{"value":"Vascular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vph.2024.107414","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107414"}}